Table 2 Time to onset of Drug-induced UI and Weibull distribution analysis.

From: Pharmacovigilance evidence of drug induced urinary incontinence in the FDA adverse event reporting system

TTO (days)

 

Weibull distribution

  

Case reports

Median (days) (IQR)

Scale parameter: α (95% CI)

Shape parameter: β (95% CI)

Type

6059

15 (0.001–159.5)

29.66 (26.54–32.78)

0.252 (0.246–0.257)

Early failure

  1. UI urinary incontinence, TTO time to onset, CI confidence interval, IQR interquartile range.